General MedicationsORALGeneric
RISPERIDONE
RISPERIDONE
Standard Dose
4MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview RISPERIDONE is listed in Drugs@FDA under application 091537 (ANDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient RISPERIDONE Form and strength TABLET, ORALLY DISINTEGRATING;ORAL - 4MG Sponsor NATCO PHARMA USA Submission history Latest submission status date: 2023-11-02 00:00:00.
Structured Monograph
Clinical summary
Approval overview RISPERIDONE is listed in Drugs@FDA under application 091537 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient RISPERIDONE Form and strength TABLET, ORALLY DISINTEGRATING;ORAL - 4MG Sponsor NATCO PHARMA USA Submission history Latest submission status date: 2023-11-02 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.